RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Anvisa Unveils New Adverse Event Database

Anvisa Unveils New Adverse Event Database

Posted 09 December 2013 | By Louise Zornoza

Brazil's national regulatory agency, Anvisa, has unveiled a new database that will gather information on adverse events relating to blood products, tissues, cells and organs. 

The database, which was developed by Italy's National Transplant Center, already includes more than 900 adverse event reports related to cell therapies, organ donations, and assisted reproduction, among others. 

The database was first unveiled at the World Health Organization's (WHO) Third Global Meeting on Biomonitoring held in Brazil from December 7 to 9, which brought together an international group of health authorities, regulators, members of national centers on disease control and epidemiology, scientific associations, and Medical Products of Human Origin (MPHO) professionals. 


Read all Breaking News from RegLink

 

© 2022 Regulatory Affairs Professionals Society.